Gritstone Asset Management »

Phoenix Biotech Acquisition shares owned by Gritstone Asset Management

Quarter-by-quarter ownership of Phoenix Biotech Acquisition (CEROW) shares owned by Gritstone Asset Management from 13F filings

Historical chart of Gritstone Asset Management investment in Phoenix Biotech Acquisition

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition held by Gritstone Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition by Gritstone Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2k 17k 0.07
2023-06-30 $1.0k 17k 0.06
2023-03-31 $682 17k 0.04
2022-12-31 $733 17k 0.04

More positions owned by Gritstone Asset Management

Ares Acquisition Corp Ii Shs Class A (AACT)
Nabors Energy Transition Cor Cl A (NETD)
Israel Acquisitions Corp Class A Ord (ISRL)
Eve Mobility Acquisition Cor Cl A Ord Shs (EVE)
Bluescape Opportunities Acqu SHS
Acropolis Infrastructure Acq Cl A
Cartesian Growth Corp Ii Class A Ord (RENE)
Silverbox Corp Iii Com Cl A (SBXC)
Investcorp India Acquistn Class A Ord Shs (IVCA)
Haymaker Acquisition Corp Iv Class A (HYAC)
Sk Growth Opportunities Corp Class A Com (SKGR)
Alchemy Invts Acquisitn Corp Shs Cl A (ALCY)
Enphys Acquisition Corp Cl A Ord Shs (NFYS)
Ares Acquisition Corporation Com Cl A
Spring Valley Acquistn Corp Class A Ord (SVII)

View all positions for Gritstone Asset Management

Top funds holding Phoenix Biotech Acquisition

Highbridge Capital Management
Cowen And Company
Cantor Fitzgerald, L. P.
MMCAP International Inc. SPC
Saba Capital Management
Shaolin Capital Management
Atalaya Capital Management
Q Global Advisors
Clear Street
Context Capital Management
Millennium Management
Highland Capital Management Fund Advisors
Ionic Capital Management
Picton Mahoney Asset Management
Westchester Capital Management

View all funds holding Phoenix Biotech Acquisition